Pirfenidone facilitates immune infiltration and enhances the antitumor efficacy of PD-L1 blockade in mice
2020
Idiopathic pulmonary fibrosis (IPF) patients have a high risk of developing lung cancer, with few treatment options available. Pirfenidone, an antifibrotic agent approved for the treatment of IPF, ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
43
References
2
Citations
NaN
KQI